Mitochondrial TDP-43 in Alzheimer's Disease
Mitochondrial TDP-43 in Alzheimer's Disease
批准号:
10578054
负责人:
Xinglong Wang
金额:
$115.47万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-15 至 2022-10-18
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, characterized by neurofibrillary
tangles, senile plaques and a progressive loss of neuronal cells in neocortex and hippocampus. Currently,
there is no effective treatment for AD. Genetic mutations in TAR DNA-binding protein 43 (TDP-43) cause
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD, the second most common form of
early-onset dementia), and the increased presence of TDP-43 in the cytoplasm is a prominent
histopathological feature of degenerating neurons in more than half of AD patients. Despite an expanding body
of evidence suggests that TDP-43 may be “the third protein” playing a distinct role in the pathogenesis of AD or
related dementia, in addition to amyloid beta (Aβ) and tau, the molecular pathomechanisms of TDP-43 remain
elusive. Interestingly, in our preliminary studies, we found that TDP-43 became highly associated with
mitochondria in AD patients, neurons treated with Aβ and APP/PS1 (5XFAD) transgenic mice for AD. Based
on identified motifs critical for TDP-43 mitochondrial localization, our most recent study revealed that the
suppression of TDP-43 mitochondrial localization was sufficient to prevent TDP-43-induced neuronal loss, and
improve behavioral performances in TDP-43 transgenic mice, indicating mitochondria as important mediators
for TDP-43 neurotoxicity. Excitingly, the inhibition of TDP-43 mitochondrial localization could significantly
alleviate neuronal death and behavioral deficits in 5XFAD mice well after symptom onset. These exciting and
promising preliminary studies suggest that a detailed investigation into the potential role of mitochondria-
associated TDP-43 in AD and related dementia is warranted. Using both cultured neuronal and transgenic
mouse models for AD and related dementia, this study will test the feasibility of targeting mitochondria-
associated TDP-43 as a novel therapeutic approach for AD and related dementia. The increased presence of
TDP-43 in the cytoplasm is a prominent common histopathological feature of degenerating neurons in various
major neurodegenerative diseases including AD, FTD and ALS. Our proposed studies of mitochondria-
associated TDP-43 and its connection with the generally believed AD culprit Aβ will have very broad scientific
and translational significance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
-
批准号:10766083
-
项目类别:
-
资助金额:$156.83万
-
财政年份:2020
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
-
批准号:10375646
-
项目类别:
-
资助金额:$61.24万
-
财政年份:2020
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial TDP-43 in Alzheimer's Disease
-
批准号:10766077
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2019
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial TDP-43 in Alzheimer's Disease
-
批准号:9815609
-
项目类别:
-
资助金额:$54.89万
-
财政年份:2019
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS
-
批准号:10329077
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2017
-
负责人:Xinglong Wang
-
依托单位:
TDP-43 and Mitochondrial Dysfunction in ALS
-
批准号:8799706
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2014
-
负责人:Xinglong Wang
-
依托单位:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
-
批准号:8620854
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
-
批准号:8490631
-
项目类别:
-
资助金额:$7.91万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
-
批准号:8729045
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
-
批准号:8636966
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TDP43作为肝癌仑伐替尼耐药新靶点对肝
癌治疗的重要作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:周洪钟
-
依托单位:
TDP-43通过CXCL10/CXCR3重塑星形胶质细胞-突触对话介导偏头痛认知障碍机制研究
-
批准号:2025JJ60697
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:龚俏宇
-
依托单位:
知母皂苷AⅢ靶向TDP-43激活cGAS/STING信号轴介导免疫原性细胞死亡发挥抗肿瘤免疫的分子机制研究
-
批准号:2024A02018
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李泽荣
-
依托单位:
TDP-43 通过抑制线粒体自噬激活
mtDNA-cGAS/STING 通路调控细胞焦亡在慢
加急肝衰竭的机制研究
-
批准号:Q24H030017
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张晓倩
-
依托单位:
TDP-43/ALKBH5通过调控CDC25A外显子跳跃介导胶质母细胞瘤瘤内异质性
-
批准号:82303932
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:谢思迪
-
依托单位:
TDP-43蛋白多态性对ALS认知功能损害及MR影像学指标影响的研究
-
批准号:CSTB2023NSCQ-MSX0427
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:周朝阳
-
依托单位:
TDP43 通过转录后调节 USP13mRNA 增强 MCL1 相分离促进卵巢癌进展以及化疗耐药
-
批准号:CSTB2023NSCQ-BHX0097
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:李梦园
-
依托单位:
DUX4-FL通过改变蛋白稳定性介导磷酸化TDP-43在肌肉内聚集的机制研究
-
批准号:82371409
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:林珉婷
-
依托单位:
基于“活性药物模板”快速筛选中药抗TDP-43蛋白异常聚集活性成分新技术研究
-
批准号:82304888
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:刘为
-
依托单位:
氧化应激通过诱导TDP-43错误定位驱动自发性肠炎的作用与机制研究
-
批准号:82300635
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:杨旭
-
依托单位: